A Clinical Study on Hemodynamic Changes by the Low Dose of Tolvaptan in Heart Failure Patients
Not Applicable
Recruiting
- Conditions
- Heart Failure
- Registration Number
- JPRN-UMIN000008028
- Lead Sponsor
- Institutional Review Board, Tokyo Women's Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1) the patient's s-Na >147mEq/L at the administration of tolvaptan 2) the patients showing shock 3) the patient's creatinine >3.0mg/dL 4) the patient showing allergy to tolvaptan 5) pregnant patient 6) the patient regarded as inappropriate for this clinical study by the principal investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hemodynamic Changes, Change of Body Weight
- Secondary Outcome Measures
Name Time Method